Production and Evaluation of Ag85B:HspX:hFcγ1 Immunogenicity as an Fc Fusion Recombinant Multi-Stage Vaccine Candidate Against Mycobacterium tuberculosis

Egedesø PJ, Hansen CW, Jensen PS (2020) Preventing the white death: tuberculosis dispensaries. Econ J 130(629):1288–1316. https://doi.org/10.1093/ej/ueaa014

Article  Google Scholar 

Cliff JM, Kaufmann SH, McShane H, van Helden P, O’Garra A (2015) The human immune response to tuberculosis and its treatment: a view from the blood. Immunol Rev 264(1):88–102. https://doi.org/10.1111/imr.12269

Article  CAS  PubMed  PubMed Central  Google Scholar 

Purmohamad A, Azimi T, Nasiri MJ, Goudarzi M, Zangiabadian M, Sedighian H et al (2020) HIV-tuberculous meningitis co-infection: a systematic review and meta-analysis. Curr Pharm Biotechnol. https://doi.org/10.2174/1389201021666200730143906

Article  Google Scholar 

Mahajan NS, Dhawale S (2015) Linked pyridinyl-thiadiazoles: design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis. Eur J Med Chem 102:243–248

Article  CAS  PubMed  Google Scholar 

Fatima S, Kumari A, Das G, Dwivedi VP (2020) Tuberculosis vaccine: a journey from BCG to present. Life Sci 252:117594. https://doi.org/10.1016/j.lfs.2020.117594

Article  CAS  PubMed  Google Scholar 

Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PEM et al (2013) Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 58(4):470–480. https://doi.org/10.1093/cid/cit790

Article  PubMed  Google Scholar 

Khoshnood S, Heidary M, Haeili M, Drancourt M, Darban-Sarokhalil D, Nasiri MJ et al (2018) Novel vaccine candidates against Mycobacterium tuberculosis. Int J Biol Macromol 120(Pt A):180–188. https://doi.org/10.1016/j.ijbiomac.2018.08.037

Article  CAS  PubMed  Google Scholar 

Kaufmann SH, Weiner J, von Reyn CF (2017) Novel approaches to tuberculosis vaccine development. Int J Infect Dis 56:263–267. https://doi.org/10.1016/j.ijid.2016.10.018

Article  PubMed  Google Scholar 

Aagaard C, Hoang T, Dietrich J, Cardona P-J, Izzo A, Dolganov G et al (2011) A multi-stage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 17(2):189

Article  CAS  PubMed  Google Scholar 

Farsiani H, Mosavat A, Soleimanpour S, Sadeghian H, Akbari Eydgahi MR, Ghazvini K et al (2016) Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6:CFP-10 complex. Mol Biosyst 12(7):2189–2201. https://doi.org/10.1039/c6mb00174b

Article  CAS  PubMed  Google Scholar 

Kebriaei A, Derakhshan M, Meshkat Z, Eidgahi MR, Rezaee SA, Farsiani H et al (2016) Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis. Mol Biol Rep 43(9):911–922. https://doi.org/10.1007/s11033-016-4024-9

Article  CAS  PubMed  Google Scholar 

Mosavat A, Soleimanpour S, Farsiani H, Sadeghian H, Ghazvini K, Sankian M et al (2016) Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine. Infect Genet Evol 39:163–172

Article  CAS  PubMed  Google Scholar 

Babaki MKZ, Taghiabadi M, Soleimanpour S, Moghadam MS, Mosavat A, Amini AA et al (2019) Mycobacterium tuberculosis Ag85b: hfcγ1 recombinant fusion protein as a selective receptor-dependent delivery system for antigen presentation. Microb Pathog 129:68–73

Article  Google Scholar 

Abebe F (2019) Synergy between Th1 and Th2 responses during Mycobacterium tuberculosis infection: a review of current understanding. Int Rev Immunol 38(4):172–179. https://doi.org/10.1080/08830185.2019.1632842

Article  CAS  PubMed  Google Scholar 

Amelio P, Portevin D, Reither K, Mhimbira F, Mpina M, Tumbo A et al (2017) Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania. PLoS Negl Trop Dis 11(7):e0005817. https://doi.org/10.1371/journal.pntd.0005817

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cardona P, Cardona PJ (2019) Regulatory T cells in Mycobacterium tuberculosis infection. Front Immunol 10:2139. https://doi.org/10.3389/fimmu.2019.02139

Article  CAS  PubMed  PubMed Central  Google Scholar 

Babaki MKZ, Soleimanpour S, Rezaee SA (2017) Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: biology, immune-pathogenicity, applications in diagnosis, and vaccine design. Microb Pathog 112:20–29

Article  Google Scholar 

Wiker HG, Harboe M (1992) The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 56(4):648–661

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forrellad MA, Klepp LI, Gioffré A, Sabio y Garcia J, Morbidoni HR, Santangelo MDLP, Cataldi AA, Bigi F (2013) Virulence factors of the Mycobacterium tuberculosis complex. Virulence 4(1):3–66. https://doi.org/10.4161/viru.22329

Article  PubMed  PubMed Central  Google Scholar 

Kuo CJ, Bell H, Hsieh CL, Ptak CP, Chang YF (2012) Novel mycobacteria antigen 85 complex binding motif on fibronectin. J Biol Chem 287(3):1892–1902. https://doi.org/10.1074/jbc.M111.298687

Article  CAS  PubMed  Google Scholar 

Ramachandra L, Smialek JL, Shank SS, Convery M, Boom WH, Harding CV (2005) Phagosomal processing of Mycobacterium tuberculosis antigen 85B is modulated independently of mycobacterial viability and phagosome maturation. Infect Immun 73(2):1097–1105. https://doi.org/10.1128/iai.73.2.1097-1105.2005

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huygen K (2014) The immunodominant T-cell epitopes of the mycolyl-transferases of the antigen 85 complex of M. tuberculosis. Front Immunol 5:321. https://doi.org/10.3389/fimmu.2014.00321

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dey B, Jain R, Gupta UD, Katoch VM, Ramanathan VD, Tyagi AK (2011) A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis. PLoS One 6(8):e23360. https://doi.org/10.1371/journal.pone.0023360

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taylor JL, Wieczorek A, Keyser AR, Grover A, Flinkstrom R, Karls RK et al (2012) HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule. Immunol Cell Biol 90(10):945–954

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levin D, Golding B, Strome SE, Sauna ZE (2015) Fc fusion as a platform technology: potential for modulating immunogenicity. Trends Biotechnol 33(1):27–34

Article  CAS  PubMed  Google Scholar 

Mohammadzadeh R, Karbalaei M, Soleimanpour S, Mosavat A, Rezaee SA, Ghazvini K et al (2021) Practical methods for expression of recombinant protein in the Pichia pastoris system. Curr Protoc 1(6):1155. https://doi.org/10.1002/cpz1.155

Article  CAS  Google Scholar 

Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25(24):4876–4882. https://doi.org/10.1093/nar/25.24.4876

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krieger E, Joo K, Lee J, Lee J, Raman S, Thompson J et al (2009) Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins 77(9):114–122

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krieger E, Koraimann G, Vriend G (2002) Increasing the precision of comparative models with YASARA NOVA—a self-parameterising force field. Proteins 47(3):393–402

Article  CAS  PubMed  Google Scholar 

Colovos C, Yeates TO (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 2(9):1511–1519. https://doi.org/10.1002/pro.5560020916

Article  CAS  PubMed  PubMed Central  Google Scholar 

Henriksen-Lacey M, Christensen D, Bramwell VW, Lindenstrøm T, Agger EM, Andersen P et al (2010) Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. J Control Release 145(2):102–108. https://doi.org/10.1016/j.jconrel.2010.03.027

Article  CAS  PubMed  Google Scholar 

Tarokhian H, Rahimi H, Mosavat A, Shirdel A, Rafatpanah H, Akbarin MM et al (2018) HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions. BMC Cancer 18(1):1287. https://doi.org/10.1186/s12885-018-5209-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mao F, Leung W-Y, Xin X (2007) Characterization of EvaGreen and the implication of its physicochemical properties for qPCR applications. BMC Biotechnol 7(1):76. https://doi.org/10.1186/1472-6750-7-76

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif